John T. Henderson

John Henderson has extensive experience in leadership and board roles within the pharmaceutical and biotechnology sectors. Currently serving as President of FuturePharm LLC since January 2001, Henderson also holds the position of Chairperson of the Board at Cytokinetics since February 2009 and has been a Non-executive Director there. Henderson's previous roles include Non-executive Director and Chairman of the Board at Myriad Genetics until December 2020, Chairman at Asmacure Inc from April 2007 to July 2015, and Non-executive Director at Myrexis Inc and Inveresk Research Group Inc. Additionally, Henderson contributed to the Scientific Advisory Board at ITI Life Sciences Scotland from 2004 to 2009, having a senior leadership background at Pfizer Inc from January 1989 until December 2000. Henderson holds a B Sc and MB ChB in Medicine from The University of Edinburgh.